Transcription Regulation In Neurodegenerative Diseases represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications.
The transcriptional landscape of the aging brain undergoes significant changes that predispose to neurodegeneration. Key alterations include:
- Dysregulation of immediate early genes (IEGs)
- Impaired activity-dependent gene expression
- Epigenetic modifications including DNA methylation and histone changes
- Altered non-coding RNA expression
YY1 is a multifunctional transcription factor that can activate or repress gene expression depending on context. It plays roles in:
- Neuronal development and differentiation
- Synaptic plasticity
- Epigenetic regulation through histone modifications
- Neuroinflammation modulation
CREB is a crucial transcription factor for neuronal survival and synaptic plasticity:
- Regulates expression of brain-derived neurotrophic factor (BDNF)
- Essential for long-term memory formation
- Impaired CREB signaling in AD and PD
- Therapeutic target for cognitive enhancement
NF-κB regulates inflammatory and survival genes:
- Activated by Aβ, α-synuclein, and mitochondrial damage
- Drives neuroinflammation in all neurodegenerative diseases
- Dual role in neuronal survival and death
flowchart TD
A[Environmental Stress] --> B[Signal Transduction] -->
B --> C{Transcription Factor Activation}
C --> D[YY1)
C --> E[CREB] -->
C --> F[NF-κB)
C --> G[p53] -->
D --> D1[Epigenetic Modification] -->
D1 --> D2[Gene Repression] -->
D2 --> D3[Synaptic Dysfunction)
E --> E1[BDNF Expression] -->
E1 --> E2[ neuronal survival] -->
E --> E3[Memory Consolidation] -->
E3 --> E4[Cognitive Decline] -->
F --> F1[Inflammatory Genes] -->
F1 --> F2[Neuroinflammation)
F2 --> F3[Neuronal Death] -->
G --> G1[Cell Cycle Re-entry] -->
G1 --> G2[Apoptosis)
D3 --> H[Neuronal Dysfunction] -->
E4 --> H
F3 --> H
H --> I[Neurodegeneration]
- Global hypomethylation in aging brains
- Hypermethylation of specific gene promoters (e.g., SNCA in PD)
- Therapeutic potential of DNA methyltransferase inhibitors
- Histone acetylation alterations affect transcription
- HDAC inhibitors show promise in preclinical models
- Balance between histone acetyltransferases (HATs) and deacetylases (HDACs)
- SWI/SNF complex dysfunction in neurodegeneration
- Altered nucleosome positioning
- Impact on neuronal activity-dependent gene programs
- CREB signaling impairment contributes to memory deficits
- YY1-mediated repression of synaptic genes
- Epigenetic changes in APP processing genes
- α-Synuclein affects TFEB and autophagy genes
- PINK1/Parkin pathway influences gene expression
- LRRK2 mutations affect transcriptional regulation
- TDP-43 aggregation disrupts RNA metabolism
- C9orf72 repeat expansions affect transcription
- Dysregulation of neuroprotective genes
| Target |
Approach |
Status |
Compounds |
| HDACs |
Inhibition |
Preclinical |
Vorinostat, SAHA |
| CREB |
Activation |
Research |
CBP agonists |
| YY1 |
Modulation |
Preclinical |
Peptide inhibitors |
| Epigenetic |
DNA methylation modulators |
Research |
5-Azacitidine |
The study of Transcription Regulation In Neurodegenerative Diseases has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Shirao T, Sekino Y. The role of drebrin in synaptic plasticity. Neuroscience Research. 2017;116:1-8.
- Shi Y, et al. YY1: a multifaceted transcription factor. Cell. 1997;89(4):555-564.
- Atallah B, et al. YY1 in neuronal development and function. Developmental Neurobiology. 2007;67(10):1390-1400.
- He Y, Casaccia-Bonnefil P. The yin and yang of YY1 in the nervous system. Journal of Neurochemistry. 2008;106(4):1493-1502.
- Acharya D, et al. YY1 and neurological disorders. Molecular Neurobiology. 2016;53(4):2580-2594.
- Lonze BE, Ginty DD. Function and regulation of CREB family transcription factors. Neuron. 2002;35(4):605-623.
- Mattson MP. Calcium and neurodegeneration. Aging Cell. 2007;6(3):337-350.
- Jiang Y, et al. Epigenetic modifications in Alzheimer's disease. Frontiers in Neuroscience. 2017;11:694.
- Coppedè F, Migliore L. DNA methylation in Alzheimer's disease. Journal of Alzheimer's Disease. 2015;45(3):703-715.
- Lu H, et al. Epigenetic regulation in Parkinson's disease. Neurochemical Research. 2017;42(1):143-152.
- Fischer A. Targeting histone-modifications in Alzheimer's disease. EMBO Molecular Medicine. 2017;9(5):603-605.
- Graff J, et al. Cognitive deficits in aged mice involve altered chromatin remodeling. Nature. 2012;486(7404):554-558.
- Benevento M, et al. Histone acetylation as a new therapeutic approach. Advances in Experimental Medicine and Biology. 2016;978:379-396.
- Rouaux C, et al. Turning neurons into neurons with HDAC inhibitors. Cell Cycle. 2007;6(21):2638-2642.
- Tyssowski KM, et al. Neuronal activity regulates transcription. Current Opinion in Neurobiology. 2018;50:222-234.
🔴 Low Confidence
| Dimension |
Score |
| Supporting Studies |
15 references |
| Replication |
0% |
| Effect Sizes |
25% |
| Contradicting Evidence |
0% |
| Mechanistic Completeness |
50% |
Overall Confidence: 38%